[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been considered ... Forced vital capacity; ICS: Inhaled corticosteroids ...

and LABAs with LAMAs and ICS. Using these drugs in combination can often improve long-term control. Within each class of inhaled asthma medication are different drugs with different brand names.

Current controller drugs for asthma include ICS, LABA, LTRA, omalizumab and theophylline. Current rescue drugs for asthma include short-acting β 2 agonists (SABA), short-acting muscarinic ...

Among patients with mild-persistent asthma with high SABA use, increased adherence to ICS decreased the proportion of patients with at least 1 exacerbation. Patients with mild asthma have a high level ...

Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended ...

In a 2017 study, researchers concluded that people with asthma who take ICS drugs tend to have suppressed immune systems and may be less able to ward off the flu than other groups. Researchers ...

Long-term inhaled corticosteroid (ICS) use for chronic obstructive pulmonary disease/ COPD (lung disease) may increase the ...

LABA as monotherapy (without ICS) for asthma can increase risk of asthma ... should be instructed to discontinue the regular use of these drugs. Avoid Excessive Use of Trelegy Ellipta and Avoid ...

mometasone furoate given in a once-daily dose – showed that the two-drug combination performed better than the ICS alone in patients with poorly-controlled asthma. The duo improved lung function ...

The pharmacologic effects of beta 2-adrenoceptor agonist drugs, including salmeterol ... LABA monotherapy (without ICS) may increase risk of asthma-related events (death, hospitalizations ...

Asthma doctors say the move will put their patients at risk of life-threatening reactions when they take the drugs at home.